Antimicrobial resistance is one of the most serious health threats facing our planet. Infections from resistant bacteria are commonplace, and some pathogens have become resistant to multiple classes of antibiotics. The loss of effective antibiotics will subvert our ability to fight infectious diseases and manage infectious complications in compromised patients undergoing an array of treatments, such as surgery and chemotherapy.
Our mission at Iasis Molecular Sciences is uncompromising. We are committed to innovate, develop and bring to market breakthrough products in advanced wound care. At the core of this effort is our collective determination to provide patients with hope for a better quality of life.